Agilent Technologies (A) Income Statement Flow — TTM through Q2 2026
Calculated from the four most recent reported quarters, ending (reported ).
Agilent Technologies (A) Revenue by Product Segment — TTM through Q2 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.
| Segment | Revenue (USD) | % of total |
|---|---|---|
| Agilent CrossLab | $3.02B | 41.7% |
| Life Sciences & Applied | $2.84B | 39.2% |
| Applied Markets | $1.38B | 19.1% |
| Total | $7.23B | 100% |
- Agilent CrossLab$3.02B
- Life Sciences & Applied$2.84B
- Applied Markets$1.38B
- Total$7.23B
Agilent Technologies (A) Revenue by Geography — TTM through Q2 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.
| Region | Revenue (USD) | % of total |
|---|---|---|
| Americas | $2.90B | 40.1% |
| Asia Pacific | $2.28B | 31.5% |
| Europe | $2.05B | 28.4% |
| Total | $7.23B | 100% |
- Americas
- Asia Pacific
- Europe
- Total
Revenue Breakdown — TTM through Q2 2026
In TTM through Q2 2026, Agilent Technologies (A) reports revenue across 3 operating segments; the largest segment was Agilent CrossLab at 41.7%, followed by Life Sciences & Applied (39.2%) and Applied Markets (19.1%). Separately, by end-market geography, Americas accounted for 40.1% of revenue, followed by Asia Pacific (31.5%) and Europe (28.4%).
Frequently asked questions
Data & methodology
Agilent Technologies (A) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation